The impact of comparative effectiveness on U.S. healthcare providers.
Comparative effectiveness research (CER) has the potential to improve health care and reduce costs, yet it is controversial. Consumers need to learn about CER to understand its benefits and limitations. Providers need to manage changing evidence about what constitutes best practices.
Bigalke
John T
JT
Deloitte LLP, Orlando, FL, USA. jbigalke@deloitte.com
D057171:American Recovery and Reinvestment Act; D057186:Comparative Effectiveness Research; D019981:Health Care Sector; D009313:National Health Programs; D014481:United States